Comparative Gene Co-expression Network Analysis of Proviral and Antiviral Responses to Dengue Virus-2 (DENV-2) and Zika Virus (ZIKV) Infection in Human Neural Progenitor Cells (hNPCs)

人类神经祖细胞(hNPCs)中登革病毒2型(DENV-2)和寨卡病毒(ZIKV)感染的促病毒和抗病毒反应的基因共表达网络比较分析

阅读:1

Abstract

The comparative proviral and antiviral mechanisms underlying host responses to Dengue virus (DENV-2) and Zika virus (ZIKV) in neural progenitor cells remain poorly understood. In this study, we first performed weighted gene co-expression network analysis (WGCNA) on RNA-seq data obtained from 30 hNPC samples infected with DENV-2 and ZIKV to compare the proviral and antiviral responses by identifying key virus-associated modules, hub genes, and enriched pathways. A total of 4,587 genes were grouped into 12 co-expression modules. The turquoise module (867 genes) showed a strong positive correlation with DENV-2 infection, whereas the green module (479 genes) showed a strong positive correlation with ZIKV infection (r = 0.92, adjusted p < 1 × 10 ⁻ ¹²). Hub genes, including CALR in the turquoise module and HMGCS1 in the green module, were found to be associated with viral replication. Functional enrichment analysis (GO, KEGG, and Reactome) revealed that both viruses modulated virus-specific and similar proviral and antiviral pathways. Among specific proviral pathways, DENV-2 infection was primarily enriched for TGF-β signaling, whereas ZIKV infection mainly engaged host translation regulation and nucleic acid-binding pathways. Similar proviral responses included endoplasmic reticulum (ER) stress and protein-folding mechanisms. Unique antiviral responses were also observed: DENV-2 triggered p53-mediated pathways, PI3K-Akt and Hippo signaling, NF-κB signaling, oxidative stress responses, and immunoglobulin class switching, whereas ZIKV infection enriched apoptotic and inflammatory pathways. Similar antiviral responses included autophagy, ubiquitin-mediated protein degradation, and Rho GTPase effector pathways. Insights from this network-based molecular study may inform the development of potential therapeutic strategies for neurological diseases associated with DENV-2 and ZIKV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。